SD BioSensor

#4336

Rank

$1.35B

MarketCap

South Korea

Country

Summary
SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.

History

Founded in 2019, SD BioSensor has grown to become a leader in providing medical imaging technologies. Our innovative systems combine visual imaging and computer-aided detection (CAD) algorithms to help medical professionals and researchers improve patient care and outcomes.


Mission
Our mission is to help create a healthier, safer world by merging the most advanced medical technologies with practical, insightful industry experience.

Vision
We envision a world where everyone has access to advanced medical technologies that enable earlier diagnosis, improved treatments, and better outcomes for patients.

Key Team

Hyo Keun Lee (Vice Chairman & CEO)

Chul-Gyu Oh (CFO & Director)

Tae Young Heo (Pres & CEO)


Recognition and Awards
SD BioSensor has won numerous awards including the Top 10 Innovative Robotics & Machines Award from the IEEE Robotics and Automation Society, the Innovate UK-Home Office Award, and the Fujifilm Research Award.

References
SD BioSensor
Leadership team

Hyo Keun Lee (Vice Chairman & CEO)

Chul-Gyu Oh (CFO & Director)

Tae Young Heo (Pres & CEO)

Products/ Services
Biotechnology, Health Care, Medical Device, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Suwon, Ch'ungch'ong-namdo, South Korea
Established
2010
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
137310.KS
Social Media
Fri Mar 01 2024
About

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with
Logo

Copyright 2023 © businessabc powered by ztudium